Abbonarsi

Impacts sur l’activité biologique de surfaces d’implants métalliques chimiquement différents couverts d’un composite de facteur de croissance des fibroblastes-2 (FGF-2) et d’apatite - 29/01/21

Impacts of chemically different surfaces of implants on a biological activity of fibroblast growth factor-2 – apatite composite layers formed on the implants

Doi : 10.1016/j.rcot.2020.10.045 
Yu Sogo a, , Kengo Fujii b, Yohei Yanagisawa b, Fumiko Kobayashi b, Shinji Murai b, Hirotaka Mutsuzaki c, Yuki Hara b, Masashi Yamazaki b, Atsuo Ito a
a Health Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566 , Japon 
b Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575 , Japon 
c Department of Orthopaedic Surgery, Ibaraki Prefectural University of Health Sciences, 4669-2 Ami Ami-machi, Inashiki-gun, Ibaraki 3000394 , Japon 

Auteur correspondant.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

pagine 2
Iconografia 0
Video 0
Altro 0

Abstract

Background

Implants coated with fibroblast growth factor-2 (FGF-2) – apatite composite layers were previously reported to enhance soft-tissue formation, bone formation, and angiogenesis around the implants owing to the biological activity of FGF-2. However, it is unclear whether the chemistries of the material and surface of implants have some impact on the retention of the biological activity of FGF-2 in FGF-2 – apatite composite layers on them. Since magnitude of the impact should be evaluated for extensive application of the composite layer to coat various implants, following items were examined: (1) surface chemistries of six implants; (2) mitogenic activities of FGF-2 in FGF-2 – apatite composite layers on the implants; and (3) improved synthesis method of the composite layer for retention of the mitogenic activity of FGF-2.

Hypothesis

The biological activity of FGF-2 in the composite layer is affected by the chemistries of the material and surface of implants.

Materials and methods

Six commercial products of pins and screws having different surface chemistries were coated with FGF-2 – apatite composite layers. The composite layers were quantitatively analyzed for calcium (Ca), phosphorus (P) and FGF-2, and also evaluated the mitogenic activities of FGF-2. Improvement of the synthesis method was then attempted using two pin products.

Results

Each commercial product had a chemically and morphologically characteristic surface. FGF-2 – apatite composite layers were formed on all the commercial products. Although the Ca, P, and FGF-2 contents (4.7±0.9μg/mm, 2.2±0.4μg/mm, and 21.1±3.7ng/mm, respectively) and the Ca/P molar ratios (1.69±0.01) of the composite layers were almost the same, rate of retention of the mitogenic activity of FGF-2 in the composite layers significantly decreased on some pin products (3/12–4/12). The decrease in rate of retention of the mitogenic activity of FGF-2 was prevented by a two-step synthesis method to form a composite layer on a precoating with calcium phosphate (9/12–12/12).

Discussion

The chemistries of the implant surfaces had a significant impact on the retention of the mitogenic activity of FGF-2 in the composite layers formed on the implant. The two-step synthesis method was useful to retain mitogenic activity of FGF-2 regardless of the surface chemistries of the implants. The two-step synthesis method has potential to expand the applicability of FGF-2 – apatite composite layers to a wider range of implants.

Level of evidence

III, case control in vitro study.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Implant surfaces, Apatite, Fibroblast growth factor-2 (FGF-2), Mitogenic activity



 Cet article peut être consulté in extenso dans la version anglaise de la revue Orthopaedics & Traumatology: Surgery & Research sur Science Direct (sciencedirect.com) en utilisant le DOI ci-dessus.


© 2021  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 107 - N° 1

P. 50-51 - febbraio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Est-ce que les implants sur mesure par impression 3D ont une valeur suffisante pour justifier leur surcoût ? Étude médico-économique comparant un implant poreux obtenu par impression 3D et son alternative proche pour le traitement des pertes de substances acétabulaires Paprosky 3B
  • Philip Tack, Jan Victor, Paul Gemmel, Lieven Annemans
| Articolo seguente Articolo seguente
  • Cupule sans ciment de révision pour arthroplastie primaire pour fracture de l’acetabulum chez des patients gériatriques ostéoporotiques
  • Christopher A. Becker, Christoph Linhart, Jan Bruder, Christian Zeckey, Axel Greiner, Adrian Cavalcanti Kußmaul, Simon Weidert, Eduardo M. Suero, Wolfgang Böcker, Christian Kammerlander

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.